These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36235011)

  • 1. Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.
    Alamri MA; Tahir Ul Qamar M; Alabbas AB; Alqahtani SM; Alossaimi MA; Azam S; Hashmi MH; Rajoka MSR
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type.
    Mohammad A; Al-Mulla F; Wei DQ; Abubaker J
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study.
    Chinnamadhu A; Ramakrishnan J; Suresh S; Poomani K
    J Biomol Struct Dyn; 2024 May; 42(8):4283-4296. PubMed ID: 37301607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    Lung J; Lin YS; Yang YH; Chou YL; Shu LH; Cheng YC; Liu HT; Wu CY
    J Med Virol; 2020 Jun; 92(6):693-697. PubMed ID: 32167173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp).
    Karthic A; Kesarwani V; Singh RK; Yadav PK; Chaturvedi N; Chauhan P; Yadav BS; Kushwaha SK
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
    Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
    Elfiky AA
    Life Sci; 2020 Jul; 253():117592. PubMed ID: 32222463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
    Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
    J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
    Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Doharey PK; Singh V; Gedda MR; Sahoo AK; Varadwaj PK; Sharma B
    J Biomol Struct Dyn; 2022 Aug; 40(12):5588-5605. PubMed ID: 33475021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
    Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
    Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase.
    Ahmed S; Mahtarin R; Islam MS; Das S; Al Mamun A; Ahmed SS; Ali MA
    J Biomol Struct Dyn; 2022; 40(21):11111-11124. PubMed ID: 34315339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
    Alrehaily A; Elfiky AA; Ibrahim IM; Ibrahim MN; Sonousi A
    Sci Rep; 2023 Dec; 13(1):23080. PubMed ID: 38155165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.
    Yashvardhini N; Jha DK; Bhattacharya S
    Arch Microbiol; 2021 Nov; 203(9):5463-5473. PubMed ID: 34410443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.